SL
AVNS

Salomon & Ludwin’s Avanos Medical AVNS Stock Holding History

Salomon & Ludwin’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.5K Hold
2,049
– – ﹤0.01% 533
2026
Q1 		$28.6K Buy
2,049
+1,322
+182% +$17.8K ﹤0.01% 811
2025
Q4 		$8.22K Sell
727
-9
-1% -$103 ﹤0.01% 1556
2025
Q3 		$8.68K Buy
+736
New +$8.62K ﹤0.01% 1418

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Salomon & Ludwin's AVNS Position: Q2 2026 in Review

Salomon & Ludwin held its Avanos Medical (AVNS) position steady in Q2 2026 at 2,049 shares worth $50.5K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

Salomon & Ludwin first reported a position in AVNS in Q3 2025 and has held it in 4 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Salomon & Ludwin held 2,049 shares of Avanos Medical worth $50.5K as of Q2 2026.
  • Salomon & Ludwin left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #533 holding.
  • Salomon & Ludwin first reported a position in Avanos Medical in Q3 2025 and has held it in 4 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.